Fine Industries, which makes fine chemicals for use in the crop protection, pharmaceutical and speciality chemicals sectors, will use the funds to increase its production capacity.
The company posted a turnover of £40m in the last fiscal year, which ended on September 30. The buyout is led by managing director Craig Morgan, who participated in the first management buyout of the company in 2008.
This is the fourth deal from NorthEdge’s fourth fund, which was closed with commitments of £225m in March this year. The firm targets businesses with an enterprise value of £10m to £100m, investing between £5m and £45m per deal.
NorthEdge partner Ray Stenton said, “Fine Industries is a high quality business that operates in a large and growing global market, with long term fundamental drivers supporting continued growth.
“As a market leader the business enjoys strong relationships with its blue chip client base.
“We are looking forward to working with the management team to support their growth plan.”
Copyright © 2013 AltAssets